Paid Clinical Trials Meridian

Discover 278 paid clinical trials in Meridian, Idaho. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter

Filter results

Results: 278

Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer

Recruiting

PHASE3

Sponsor:

National Cancer Institute (NCI)

Location:

Meridian, Boise, Nampa, Caldwellshow 395 more

Code:

NCT04181060

Conditions

Advanced Lung Non-Squamous Non-Small Cell Carcinoma

Metastatic Lung Non-Squamous Non-Small Cell Carcinoma

Recurrent Lung Non-Squamous Non-Small Cell Carcinoma

Stage IIIB Lung Cancer AJCC v8

Stage IV Lung Cancer AJCC v8

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Bevacizumab

Biospecimen Collection

Computed Tomography

Echocardiography

Magnetic Resonance Imaging

Natural History Study of Exocrine Pancreatic Function in Infants With Cystic Fibrosis (CF)

Recruiting

Sponsor:

Vertex Pharmaceuticals Incorporated

Location:

Boise, Spokane, Billings, Vancouvershow 21 more

Code:

NCT06506773

Conditions

Cystic Fibrosis

Eligibility Criteria

Sex: All

Age: 0 - 6

Healthy Volunteers: Not accepted

Comparing Two Methods to Follow Patients With Pancreatic Cysts

Recruiting

Sponsor:

ECOG-ACRIN Cancer Research Group

Location:

Meridian, Boise, Nampa, Fruitlandshow 224 more

Code:

NCT04239573

Conditions

Pancreatic Carcinoma

Eligibility Criteria

Sex: All

Age: 50 - 70+

Healthy Volunteers: Not accepted

Interventions

Computed Tomography

Endoscopic Ultrasound

Magnetic Resonance Imaging

Quality-of-Life Assessment

Questionnaire Administration

A Switch Study From High-Sodium Oxybate to XYWAV to Evaluate Changes in Blood Pressure in Participants With Narcolepsy

Recruiting

Sponsor:

Jazz Pharmaceuticals

Location:

Nampa, Portland, San Ramon, Las Vegasshow 29 more

Code:

NCT05869773

Conditions

Narcolepsy

Eligibility Criteria

Sex: All

Age: 18 - 70

Healthy Volunteers: Not accepted

Interventions

JZP258

MILD® Percutaneous Image-Guided Lumbar Decompression: a Medicare Claims Study

Recruiting

Sponsor:

Vertos Medical, Inc.

Location:

Meridian, Boise, Nampa, Blackfootshow 944 more

Code:

NCT03072927

Conditions

Lumbar Spinal Stenosis

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

MILD

Interspinous Process Decompression

Prospective Study of Pregnancy in Women With Cystic Fibrosis

Recruiting

Sponsor:

Amalia Magaret

Location:

Boise, Salt Lake City, Portland, Seattleshow 35 more

Code:

NCT04828382

Conditions

Pregnancy Related

Cystic Fibrosis

Eligibility Criteria

Sex: Female

Age: 16+

Healthy Volunteers: Not accepted

Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Effects of EP262 in Subjects With Chronic Spontaneous Urticaria

Recruiting

PHASE2

Sponsor:

Escient Pharmaceuticals, Inc

Location:

Boise, Missoula, Murray, North Las Vegasshow 32 more

Code:

NCT06077773

Conditions

Chronic Spontaneous Urticaria

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Oral EP262

Placebo

A Study of RGLS8429 in Patients With Autosomal Dominant Polycystic Kidney Disease

Recruiting

PHASE1

Sponsor:

Regulus Therapeutics Inc.

Location:

Boise, Chubbuck, Idaho Falls, Seattleshow 23 more

Code:

NCT05521191

Conditions

Autosomal Dominant Polycystic Kidney Disease

ADPKD

Polycystic Kidney, Autosomal Dominant

Eligibility Criteria

Sex: All

Age: 18 - 70

Healthy Volunteers: Not accepted

Interventions

RGLS8429

Placebo

A Study to Customize Ibrutinib Treatment Regimens for Participants With Previously Untreated Chronic Lymphocytic Leukemia

Recruiting

PHASE2

Sponsor:

Janssen Research & Development, LLC

Location:

Boise, Ogden, Eugene, Portlandshow 27 more

Code:

NCT05963074

Conditions

Leukemia, Lymphocytic, Chronic, B-Cell

Small Lymphocytic Lymphoma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Ibrutinib

Venetoclax

A 12-Month Study of Lasmiditan (LY573144) Treatment in Children Aged 6 to 17 With Migraine

Recruiting

PHASE3

Sponsor:

Eli Lilly and Company

Location:

Meridian, Ammon, Logan, Portlandshow 73 more

Code:

NCT04396574

Conditions

Migraine

Eligibility Criteria

Sex: All

Age: 6 - 17

Healthy Volunteers: Not accepted

Interventions

Lasmiditan